Company intelligence / Profile preview

Platomics

Ownership: Private
Employees: ~77
Development stage: Other

Overview

Platomics has developed the PlatoX platform to automate regulatory compliance processes in the in vitro diagnostic sector. The company’s solution supports laboratories and manufacturers with IVDR compliance by providing workflow documentation, guidance, secure data management, and a regulatory knowledge base. The system is ISO 13485-certified since 2018 and operates from an ISO 27001-certified data center in Vienna. No clinical trial results are relevant as this is not a drug/device developer but rather an infrastructure/platform provider.

Modalities: DeviceDigital HealthSoftware Platform
Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

No major pharmaceutical or biotech partnerships specifically named in available sources.

Beyond the preview

Go deeper on Platomics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Platomics.

Explore the full profile